DIVERSA CORP
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: DIVERSA CORP, 10-Q, EX-10.39, 2000-11-14
Next: UNITED PANAM FINANCIAL CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Company's condensed balance sheet as of September 30, 2000, and the related
condensed statements of operations of the nine months ended September 30, 2000
and the notes thereto, and is qualified in its entirety by reference to such
condensed financial statements and notes.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          93,327
<SECURITIES>                                   117,035
<RECEIVABLES>                                      752
<ALLOWANCES>                                         0
<INVENTORY>                                         51
<CURRENT-ASSETS>                               211,881
<PP&E>                                          17,869
<DEPRECIATION>                                   6,763
<TOTAL-ASSETS>                                 230,224
<CURRENT-LIABILITIES>                           11,921
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            35
<OTHER-SE>                                     192,868
<TOTAL-LIABILITY-AND-EQUITY>                   230,224
<SALES>                                              0
<TOTAL-REVENUES>                                15,357
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (7,485)
<INCOME-TAX>                                       225
<INCOME-CONTINUING>                            (7,710)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,020)<F1>
<EPS-BASIC>                                     (0.27)
<EPS-DILUTED>                                   (0.27)


<FN>
Includes dividends on preferred stock of $310. </FN>

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission